313 related articles for article (PubMed ID: 34439332)
1. Ovarian Cancer and Cancer Stem Cells-Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology.
Nowicki A; Kulus M; Wieczorkiewicz M; Pieńkowski W; Stefańska K; Skupin-Mrugalska P; Bryl R; Mozdziak P; Kempisty B; Piotrowska-Kempisty H
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439332
[TBL] [Abstract][Full Text] [Related]
2. Presence and role of stem cells in ovarian cancer.
Kenda Suster N; Virant-Klun I
World J Stem Cells; 2019 Jul; 11(7):383-397. PubMed ID: 31396367
[TBL] [Abstract][Full Text] [Related]
3. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors.
Parte SC; Batra SK; Kakar SS
J Ovarian Res; 2018 Aug; 11(1):69. PubMed ID: 30121075
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling.
Raghavan S; Snyder CS; Wang A; McLean K; Zamarin D; Buckanovich RJ; Mehta G
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726910
[TBL] [Abstract][Full Text] [Related]
7. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
8. Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
Roy L; Cowden Dahl KD
Cancers (Basel); 2018 Jul; 10(8):. PubMed ID: 30042330
[TBL] [Abstract][Full Text] [Related]
9. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
Bosukonda A; Carlson WD
Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
Jayachandran A; Dhungel B; Steel JC
J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells and tumorigenesis.
Zhu P; Fan Z
Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
[TBL] [Abstract][Full Text] [Related]
16. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
17. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
[TBL] [Abstract][Full Text] [Related]
18. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
20. How to win the ovarian cancer stem cell battle: destroying the roots.
Takahashi A; Hong L; Chefetz I
Cancer Drug Resist; 2020; 3(4):1021-1033. PubMed ID: 35582216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
